A highly immunogenic novel genetic vaccine against HCV by Del Sorbo, M, Capone, S, Antrobus, R, Swadling, L, Brown, A, Richardson, R, Kurioka, A, Colloca, S, Naddeo, M, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P, Folgori, A, Barnes, E

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES by Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES by Barnes, E, Antonella, F, Aston, S, Smith, K, Brown, A, Capone, S, Ambrosio, M, Harrison, G, Ammendola, V, Bartiromo, M, Traboni, C, Siani, L, Sparacino, A, Naddeo, M, Colloca, S, Cortese, R, Nicosia, A, Klenerman, P

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION by Kelly, C, Folgori, A, Capone, S, Brown, A, Swadling, L, Townsend, R, Halliday, J, Stafford, E, O'Donnell, D, Naddeo, M, Collier, J, Adams, D, Colloca, S, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P, Barnes, E

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS by Barnes, E, Folgori, A, Capone, S, Aston, S, Meyer, J, Gantlett, K, Smith, K, Huddart, R, Brown, A, Kurioka, A, Humphreys, I, Harrison, G, Kelly, C, Ammendola, V, Colloca, S, Naddeo, M, Siani, L, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults. by Green, C, Scarselli, E, Sande, C, Thompson, A, de Lara, C, Taylor, K, Haworth, K, Del Sorbo, M, Angus, B, Siani, L, Di Marco, S, Traboni, C, Folgori, A, Colloca, S, Capone, S, Vitelli, A, Cortese, R, Klenerman, P, Nicosia, A, Pollard, A

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection by Swadling, L, Halliday, J, Kelly, C, Brown, A, Capone, S, Ansari, M, Bonsall, D, Richardson, R, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Von Delft, A, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P, Folgori, A, Barnes, E

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS by Kelly, C, Folgori, A, Capone, S, Stafford, E, O'Donnell, D, Gantlett, K, Collier, J, Brown, A, Huddart, R, Humphreys, I, Kurioka, A, Townsend, R, Swadling, L, Ammendola, V, Colloca, S, Naddeo, M, Siani, L, Traboni, C, Cortese, R, Nicosia, A, Klenerman, P, Barnes, E

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection by Swadling, L, Halliday, J, Kelly, C, Brown, A, Capone, S, Ansari, M, Bonsall, D, Richardson, R, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Von Delft, A, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P, Folgori, A, Barnes, E

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species. by Colloca, S, Barnes, E, Folgori, A, Ammendola, V, Capone, S, Cirillo, A, Siani, L, Naddeo, M, Grazioli, F, Esposito, M, Ambrosio, M, Sparacino, A, Bartiromo, M, Meola, A, Smith, K, Kurioka, A, O'Hara, G, Ewer, K, Anagnostou, N, Bliss, C, Hill, A, Traboni, C, Klenerman, P, Cortese, R, Nicosia, A

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory by Swadling, L, Capone, S, Antrobus, R, Brown, A, Richardson, R, Newell, E, Halliday, J, Kelly, C, Bowen, D, Fergusson, J, Kurioka, A, Ammendola, V, Del Sorbo, M, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Hill, A, Colloca, S, Davis, M, Nicosia, A, Cortese, R, Folgori, A, Klenerman, P, Barnes, E

Hepatitis Hide and Seek by Barnes, E, Folgori, A, Capone, S, Swadling, L, Aston, S, Kurioka, A, Meyer, J, Huddart, R, Smith, K, Townsend, R, Brown, A, Antrobus, R, Ammendola, V, Naddeo, M, O'Hara, G, Willberg, C, Harrison, A, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Oo, Y, Adams, D, Hill, A, Colloca, S

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans by Kelly, C, Swadling, L, Capone, S, Brown, A, Richardson, R, Halliday, J, von Delft, A, Oo, Y, Mutimer, D, Kurioka, A, Hartnell, F, Collier, J, Ammendola, V, Sorbo, M, Grazioli, F, Esposito, M, Marco, S, Siani, L, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Folgori, A, Klenerman, P, Barnes, E

Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans. by Kelly, C, Swadling, L, Capone, S, Brown, A, Richardson, R, Halliday, J, von Delft, A, Oo, Y, Mutimer, D, Kurioka, A, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Grazioli, F, Luisa Esposito, M, Di Marco, S, Siani, L, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Folgori, A, Klenerman, P, Barnes, E

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man by Barnes, E, Folgori, A, Capone, S, Swadling, L, Aston, S, Kurioka, A, Meyer, J, Huddart, R, Smith, K, Townsend, R, Brown, A, Antrobus, R, Ammendola, V, Naddeo, M, O'Hara, G, Willberg, C, Harrison, A, Grazioli, F, Esposito, M, Siani, L, Traboni, C, Oo, Y, Adams, D, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P